Woodline Partners »

Revance Therapeutics shares owned by Woodline Partners

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.1M 798k 5.19
2023-06-30 $2.7M 108k 25.31
2021-09-30 $4.9M 175k 27.86